Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity

References

• ArdenGSidmanRArapWSchlingemannR2005Spare the rod and spoil the eyeBr J Ophthalmol897646915923516
   PubMed Web of Science ®Google Scholar
• AveryRPieramiciDRabenaMCastellarinANasirMGuistM2006Intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmology1133637216458968
   PubMed Web of Science ®Google Scholar
• BaileyILovieJ1976New design principles for visual acuity letter chartsAm J Optom Physiol Opt537405998716
   PubMedGoogle Scholar
• BrownDKaiserPMichelsMSoubraneGHeierJKimRSyJSchneiderSfor the ANCHOR Study Group2006Ranibizumab versus verteporfin for neovascular Age-related macular degenerationN Engl J Med35514324417021319
   PubMed Web of Science ®Google Scholar
• CostaRJorgeRCalucciDCardilloJMeloLAJScottI2006Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation studyInvest Ophthalmol Vis Sci4745697817003454
   PubMed Web of Science ®Google Scholar
• DhallaMShahGBlinderKRyanEJMittraRTewariA2006Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degenerationRetina299889317151484
   PubMed Web of Science ®Google Scholar
• FeiglBBrownBLovie-KitchinJLeeL2005Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of casesDoc Ophthalmol1111354816523231
   PubMed Web of Science ®Google Scholar
• FeiglBBrownBLovie-KitchinJSwannP2007Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesisEye216899616680100
   PubMed Web of Science ®Google Scholar
• FeiglBStewartIBrownB2007Experimental hypoxia in human eyes: implications for ischaemic diseaseClin Neurophysiol1188879517307390
   PubMed Web of Science ®Google Scholar
• GalvanVGreenbergDJinK2006The role of vascular endothelial growth factor in neurogenesis in adult brainMini Rev Med Chem66676916787377
   PubMed Web of Science ®Google Scholar
• GaudreaultJFeiDRusitJSubocPShiuV2005Preclinical pharmacokinetics of ranibizumab (fhuFabV2) after a single intravitreal administrationInvest Ophthalmol Vis Sci467263315671306
   PubMed Web of Science ®Google Scholar
• GerberHHillanKRyanAKowalskiJKellerGRangellLWrightBRadtkeFAguetMFerraraN1999VEGF is required for growth and survival in neonatal miceDevelopment12611495910021335
   PubMed Web of Science ®Google Scholar
• GerthCHauseDDelahuntPMorseLWernerJ2003Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics with large drusenArch Ophthalmol12114041414557176
   PubMedGoogle Scholar
• GragoudasEAdamisACunninghamEFeinsodMGuyerDfor the VEGF Inhibition Study in Ocular Neovascularisation Clinical Trial Group2004Pegaptanib for neovascular age-related macular degenerationN Engl J Med35128051615625332
   PubMed Web of Science ®Google Scholar
• GreensteinVChenHHoodDSeipleWCarrR2000Retinal function in diabetic macular edema after focal laser photocoagulationInvest Ophthalmol Vis Sci4136556411006264
   PubMed Web of Science ®Google Scholar
• GrunwaldJHariprasadSDuPontJMaguireMFineSBruckerAMaguireAHoA1998Foveal choroidal blood flow in age-related macular degeneration (AMD)Invest Ophthalmol Vis Sci39385909477998
   PubMed Web of Science ®Google Scholar
• GrunwaldJMetelitsinaTDuPontJYingG-SMaguireM2005Reduced foveolar choroidal blood flow in eyes with increasing AMD severityInvest Ophthalmol Vis Sci4610333815728562
   PubMed Web of Science ®Google Scholar
• HeeMIzattJSwansonEHuangDSchumanJLinCPuliafitoCFuji-motoJ1995Optical coherence tomography of the human retinaArch Ophthalmol113325327887846
   PubMed Web of Science ®Google Scholar
• HeierJBoyerDCiullaTFerronePJumperJGentileRKotlovkerDChungCKimR2006Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS StudyArch Ophthalmol12415324217101999
   PubMed Web of Science ®Google Scholar
• HoodDFrishmanLSaszikSViswanathanS2002Retinal origins of the primate multifocal ERG. Implication for the human responseInvest Ophthalmol Vis Sci4316738511980890
   PubMed Web of Science ®Google Scholar
• JurkliesBWeismannMSutterEBornfeldN2002Monitoring retinal function in neovascular maculopathy using multifocal electroretinography-early and long-term correlation with clinical findingsGraefe’s Arch Clin Exp Ophthalmol24024464
   PubMed Web of Science ®Google Scholar
• LalwaniGFungAMichelsSVenkatramanAPuliafitoCRosenfeldP2006Optical coherence tomography findings in a variable-dosing regimen with ranibizumab (Lucentis): The PrONTO StudyAnnual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)E-abstract 2147
   Google Scholar
• ManleyPMartiny-BaronGSchlaeppiJWoodJ2002Therapies directed at vascular endothelial growth factorExpert Opin Investig Drugs11171536
   PubMed Web of Science ®Google Scholar
• ManzanoRPeymanGKhanPKivilcimM2006Testing intravitreal toxicity of bevacizumab (Avastin)Retina262576116508423
   PubMed Web of Science ®Google Scholar
• MarnerosAFanJYokoyamaYGerberHFerraraNCrouchROlsenB2005Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual functionAm J Pathol1671451916251428
   PubMed Web of Science ®Google Scholar
• MaturiRBleauLWilsonD2006Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatmentRetina26270416508425
   PubMed Web of Science ®Google Scholar
• MaulikN2006Reactive oxygen species drives myocardial angiogenesisAntioxid Redox Signal82161817034358
   PubMed Web of Science ®Google Scholar
• McLeodDTaomotoMOtsujiTGreenWSunnessJLuttyG2002Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degenerationInvest Ophthalmol Vis Sci4319869312037009
   PubMed Web of Science ®Google Scholar
• MoschosMApostolopoulosMLadasITheodossiadisPMaliasJMoschosMTheodossiadisG2001Assessment of macular function by multifocal electroretinogram before and after epimacular membrane surgeryRetina21590511756881
   PubMed Web of Science ®Google Scholar
• MoschosMBrouzasDApostolopoulosMKoutsandreaCLoukianouEMoschosM2007Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study: Multifocal-ERG after use of bevacizumab in ARMDDoc Ophthalmol114374417216267
   PubMed Web of Science ®Google Scholar
• PauleikhoffDChenJChisholmIBirdA1990Choroidal perfusion abnormality with age-related Bruch’s membrane changeAm J Ophthalmol10921172301534
   PubMed Web of Science ®Google Scholar
• PelliDRobsonJWilkinsA1988The design of a new letter chart for measuring contrast sensitivityClin Vis Sci218799
   Google Scholar
• RobinsonGJuMShihSCXuXMcMahonGCaldwellRSmithL2001Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal developmentFASEB J151215711344092
   PubMed Web of Science ®Google Scholar
• RosenfeldP2006Intravitreal avastin: the low cost alternative to lucentis?Am J Ophthalmol142141316815262
   PubMed Web of Science ®Google Scholar
• RosenfeldPBrownDHeierJBoyerDKaiserPChungCKimRMARINA Study Group2006Ranibizumab for neovascular age-related macular degenerationN Engl J Med35514193117021318
   PubMed Web of Science ®Google Scholar
• RosenfeldPFungALalwaniGMichelsSVenkatramanAPuliafitoC2006Visual acuity outcomes following a variable-dosing regimen for ranibizumab (lucentis) in neovascular AMD: The PrONTO StudyAnnual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)ARVO Abstract 2958
   Google Scholar
• RosenfeldPHeierJHantsbargerGShamsN2006Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degenerationOphthalmology113632e631
   Web of Science ®Google Scholar
• RosenfeldPRichRLalwaniG2006Ranibizumab: Phase III Clinical Trial ResultsOphthalmol Clin North Am193617216935211
   PubMedGoogle Scholar
• RubinGBresslerNthe Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group2002Effects of Verteporfin therapy on contrast sensitivity. Results from the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No. 4Retina225364412441717
   PubMed Web of Science ®Google Scholar
• SarksJSarksSKillingworthM1988Evolution of geographic atrophy of the retinal pigment epitheliumEye2552772476333
   PubMed Web of Science ®Google Scholar
• SarksS1976Ageing and degeneration in the macular region: a clinicopathological studyBr J Ophthalmol6032441952802
   PubMed Web of Science ®Google Scholar
• SchlingemannR2004Role of growth factors and the wound healing response in age-related macular degenerationGraefe’s Arch Clin Exp Ophthalmol24291101
   PubMed Web of Science ®Google Scholar
• ShaharJAveryRHeilweilGBarakAZemelELewisGJohnsonPFisherSPerlmanILoewensteinA2006Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)Retina26262916508424
   PubMed Web of Science ®Google Scholar
• StorkebaumELambrechtsDCarmelietP2004VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotectionBioessays269435415351965
   PubMed Web of Science ®Google Scholar
• SutterETranD1992The field topography of ERG components in man-I. the photopic luminance responseVision Res32433461604830
   PubMed Web of Science ®Google Scholar
• VEGF Inhibition Study In Ocular Neovascularization (V.I.S.I.O.N) Clinical Trial Group2006Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degenerationOphthalmology1131508.e12516828500
   PubMed Web of Science ®Google Scholar
• WitmerAVrensenGVan NoordenCSchlingemannR2003Vascular endothelial growth factors and angiogenesis in eye diseaseProg Ret Eye Res22129
   PubMed Web of Science ®Google Scholar
• ZeleAJVingrysAJ2005Cathode-ray-tube monitor artefacts in neurophysiologyJ Neurosci Meth14117
   Web of Science ®Google Scholar